Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep334 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Antipsychotic induced obesity in schizophrenia and GLP-1 analog treatment? – A case-report

Iva Jakubíková , Martin Haluzík MD DSc

IntroductionSchizophrenia is one of the seven most disabling diseases according to World Health Organization. The most potent antipsychotic drugs clozapine and olanzapine are associated with excessive weight gain. Premature deaths in schizophrenia and shorter life expectancy are mainly caused by obesity-related cardiovascular diseases. Obesity itself is associated with brain deterioration, cognitive decline and overall worse quality of life. GLP-1 recept...